BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33152351)

  • 21. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation.
    Huang L; Zhang SM; Zhang P; Zhang XJ; Zhu LH; Chen K; Gao L; Zhang Y; Kong XJ; Tian S; Zhang XD; Li H
    J Am Heart Assoc; 2014 Oct; 3(5):e001309. PubMed ID: 25304854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
    McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
    Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats.
    Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA
    Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SMYD2-Methylated PPARγ Facilitates Hypoxia-Induced Pulmonary Hypertension by Activating Mitophagy.
    Li Y; Wei X; Xiao R; Chen Y; Xiong T; Fang ZM; Huo B; Guo X; Luo H; Wu X; Liu L; Zhu XH; Hu Q; Jiang DS; Yi X
    Circ Res; 2024 Jun; 135(1):93-109. PubMed ID: 38770649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension.
    Lee FY; Lu HI; Zhen YY; Leu S; Chen YL; Tsai TH; Chung SY; Chua S; Sheu JJ; Hsu SY; Chang HW; Sun CK; Yip HK
    Eur J Pharm Sci; 2013 Nov; 50(3-4):372-84. PubMed ID: 23954457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis.
    Barman SA; Li X; Haigh S; Kondrikov D; Mahboubi K; Bordan Z; Stepp DW; Zhou J; Wang Y; Weintraub DS; Traber P; Snider W; Jonigk D; Sullivan J; Crislip GR; Butcher JT; Thompson J; Su Y; Chen F; Fulton DJR
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L784-L797. PubMed ID: 30724100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.
    Preston IR; Sagliani KD; Warburton RR; Hill NS; Fanburg BL; Jaffe IZ
    Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(10):L678-88. PubMed ID: 23457185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
    Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
    Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration.
    Cao N; Aikeremu N; Shi WY; Tang XC; Gao RJ; Kong LJ; Zhang JR; Qin WJ; Zhang AM; Ma KT; Li L; Si JQ
    Int J Mol Med; 2022 Sep; 50(3):. PubMed ID: 35856410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
    Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
    Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphatidylinositol 3-Kinase-DNA Methyltransferase 1-miR-1281-Histone Deacetylase 4 Regulatory Axis Mediates Platelet-Derived Growth Factor-Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells.
    Li Y; Li L; Qian Z; Lin B; Chen J; Luo Y; Qu J; Raj JU; Gou D
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects.
    Kishimoto Y; Kato T; Ito M; Azuma Y; Fukasawa Y; Ohno K; Kojima S
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):645-54.e3. PubMed ID: 26095621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
    Paffett ML; Lucas SN; Campen MJ
    Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
    Wang Y; Dai S; Cheng X; Prado E; Yan L; Hu J; He Q; Lv Y; Lv Y; Du L
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):639-651. PubMed ID: 30954415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
    Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
    Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y
    Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
    Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.